Skip to main content
SpringerLink
Log in

„Dallas steatosis index“ zur Vorhersage der nichtalkoholischen Fettlebererkrankung

Dallas steatosis index for the prediction of nonalcoholic fatty liver disease

  • Journal Club
  • Published:
Der Diabetologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Victor RG, Haley RW, Willett DL et al (2004) The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 93(12):1473–1480

    Article  Google Scholar 

  2. Long MT, Pedley A, Colantonio LD et al (2016) Development and validation of the Framingham steatosis index to identify persons with hepatic steatosis. Clin Gastroenterol Hepatol 14(8):1172–1180.e2

    Article  Google Scholar 

  3. Lee JH, Kim D, Kim HJ et al (2010) Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 42(7):503–508

    Article  CAS  Google Scholar 

  4. Bedogni G, Bellentani S, Miglioli L et al (2006) The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6:33

    Article  Google Scholar 

  5. Ruhl CE, Everhart JE (2015) Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment Pharmacol Ther 41(1):65–76

    Article  CAS  Google Scholar 

  6. Serra-Burriel M, Graupera I, Torán P et al (2019) Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia. J Hepatol 71(6):1141–1151

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für klinische Diabetologie, Deutsches Diabetes-Zentrum an der Heinrich-Heine-Universität, Leibniz-Zentrum für Diabetesforschung, Auf’m Hennekamp 65, 40225, Düsseldorf, Deutschland

    Sabine Kahl

Authors
  1. Sabine Kahl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sabine Kahl.

Ethics declarations

Interessenkonflikt

S. Kahl gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kahl, S. „Dallas steatosis index“ zur Vorhersage der nichtalkoholischen Fettlebererkrankung. Diabetologe 16, 749–750 (2020). https://doi.org/10.1007/s11428-020-00692-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-020-00692-x

Search

Navigation